IL13 and adrenal cortex carcinoma: The expression of IL-13-Ra2 by some tumors provided a scientific rationale for a phase 1 study of the recombinant cytotoxin IL-13-PE, consisting of human IL-13 and a truncated form of Pseudomonas exotoxin (PE) A in ACC patients [108].